Skip to main content

Cervical Dystonia News

Related terms: Torticollis

FDA Approves First Therapeutic Indication for Revance’s Daxxify (daxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

Provides Revance entry into the $2.5 billion U.S. therapeutic neuromodulator market.1 Approval expands the Daxxify® label to include efficacy data over the 52-week ASPEN repeat dose clinical study. ...

FDA Approves Merz Pharmaceuticals' Xeomin (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm

GREENSBORO, N.C., Aug. 2 /PRNewswire/ – Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA), a botulinum...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

lorazepam, baclofen, Botox